Composition and method for rapidly inducing an endogenous ketosis
View Patent ↗A composition and method for rapidly inducing a state of endogenous ketosis, the composition including: about 26.66-28.57 percent by mass of alpha lipoic acid; about 0.01-0.02 percent by mass of chromium picolinate; about 47.61-49.99 percent by mass of L-arginine; and, about 23.33-23.81 percent by mass of calcium carbonate. The method includes restricting carbohydrate consumption to a maximum dosage of about 20 grams prior to consumption of the composition and wherein consumption of the composition is on an empty stomach. About thirty minutes after consumption of the composition the user performs moderate intensity exercise. About three hours after consuming a first dose the user tests for a presence of ketones in urine utilizing at least one sodium nitroprusside urine ketone reagent strip.
1. A composition for rapidly inducing a state of endogenous ketosis when the composition is accompanied with carbohydrate restriction in a maximum dosage of about 20 grams per day by a user, the composition comprising of:
about 26.66-28.57 percent by mass of alpha lipoic acid;
about 0.01-0.02 percent by mass of chromium picolinate;
about 47.61-49.99 percent by mass of L-arginine;
about 23.33-23.81 percent by mass of calcium carbonate; and,
wherein the composition further comprises zero percent by mass of ketones, zero percent by mass of beta-hydroxybutyrate, and zero percent by mass of carbohydrate.
2. The composition of claim 1 , wherein the composition is configured to be consumed orally.
3. A method for rapidly inducing a state of endogenous ketosis when accompanied with carbohydrate restriction in a maximum dosage of about 20 grams per day by a user, the method comprising:
restricting carbohydrate consumption to the maximum dosage of about 20 grams per day; and,
consuming a composition comprising:
zero percent by mass of ketones, zero percent by mass carbohydrates, and zero percent by mass beta-hydroxybutyrate;
about 26.66-28.57 percent by mass of alpha lipoic acid;
about 0.01-0.02 percent by mass of chromium picolinate;
about 47.61-49.99 percent by mass of L-arginine; and,
about 23.33-23.81 percent by mass of calcium carbonate.
4. The method of claim 3 , wherein said carbohydrate restriction of the maximum dosage of about 20 grams is prior to consumption of the composition.
5. The method of claim 3 , wherein the consumption of the composition is on an empty stomach.
6. The method of claim 5 , wherein about thirty minutes after consumption of the composition the user performs moderate intensity exercise.
7. The method of claim 5 , wherein about three hours after consuming a first dose of the composition, the user tests for a presence of ketones in urine utilizing at least one sodium nitroprusside urine ketone reagent strip.
8. The method of claim 7 , wherein if a state of endogenous ketosis has not been reached as indicated by a positive ketone test utilizing the at least one sodium nitroprusside urine ketone test strip then a user consumes a subsequent dose of the composition.
9. The method of claim 8 , wherein beginning about one hour after consuming the subsequent dose of the composition, the user randomly tests for the presence ketones in urine utilizing the at least one sodium nitroprusside urine ketone reagent strip until a state of endogenous ketosis has been reached.
10. The composition of claim 1 , wherein a sum total weight of the alpha lipoic acid, the chromium picolinate, the L-arginine, and the calcium carbonate is from 2100.2 to 3000.5 mg.
11. A composition for rapidly inducing a state of endogenous ketosis when the composition is accompanied with carbohydrate restriction in a maximum dosage of about 20 grams per day by a user, the composition comprising:
600 to 800 mg of alpha lipoic acid;
200 to 500 micrograms of chromium picolinate;
1000 to 1500 mg of L-arginine;
500 to 700 mg of calcium carbonate; and,
wherein the composition further comprises zero grams of ketones, zero grams of beta-hydroxybutyrate, and zero grams of carbohydrates.
12. The composition of claim 11 , wherein the composition is configured to be consumed orally.